We are live on ! Find out more
SRC

Stone Run Capital Portfolio holdings

AUM $254M
1-Year Est. Return 12.86%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$153M
AUM Growth
-$1.65M
Cap. Flow
-$8.83M
Cap. Flow %
-5.75%
Top 10 Hldgs %
34.41%
Holding
71
New
4
Increased
12
Reduced
14
Closed
4

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$1.91M
2
ILMN icon
Illumina
ILMN
+$869K
3
WTS icon
Watts Water Technologies
WTS
+$770K
4
CLB icon
Core Laboratories
CLB
+$311K
5
ABBV icon
AbbVie
ABBV
+$262K

Top Sells

Rank Stock Value
1
ARG
Airgas Inc
ARG
+$5.57M
2
FMC icon
FMC
FMC
+$2.48M
3
CLC
Clarcor
CLC
+$2.14M
4
LH icon
Labcorp
LH
+$827K
5
MTX icon
Minerals Technologies
MTX
+$792K

Sector Composition

Rank Sector Weight
1 Healthcare 25.15%
2 Industrials 19.04%
3 Materials 15.55%
4 Technology 14.65%
5 Energy 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCR
1
DELISTED
CR Bard Inc.
BCR
$6.41M 4.18%
27,250
-50
-0.2% -$10.9K
PX
2
DELISTED
Praxair Inc
PX
$5.68M 3.7%
50,575
-4,175
-8% -$474K
XRAY icon
3
Dentsply Sirona
XRAY
$2.68B
$5.46M 3.56%
88,065
– –
SLB icon
4
SLB Ltd
SLB
$73.6B
$5.39M 3.51%
68,124
+24,950
+58% +$1.91M
MHK icon
5
Mohawk Industries
MHK
$7.5B
$5.28M 3.44%
27,825
– –
IFF icon
6
International Flavors & Fragrances
IFF
$20.2B
$5.28M 3.44%
41,875
– –
EMR icon
7
Emerson Electric
EMR
$83.9B
$5.2M 3.39%
99,650
+4,900
+5% +$260K
TECH icon
8
Bio-Techne
TECH
$11.2B
$5.09M 3.32%
180,600
-2,000
-1% -$51.4K
EW icon
9
Edwards Lifesciences
EW
$49.6B
$4.57M 2.98%
137,400
-10,500
-7% -$359K
IHS
10
DELISTED
IHS INC CL-A COM STK
IHS
$4.43M 2.89%
38,345
-2,800
-7% -$336K
MKC icon
11
McCormick & Company Non-Voting
MKC
$13.7B
$4.14M 2.7%
77,550
– –
WTS icon
12
Watts Water Technologies
WTS
$11.5B
$4.11M 2.68%
70,453
+13,600
+24% +$770K
BDX icon
13
Becton Dickinson
BDX
$45.6B
$3.85M 2.51%
23,298
– –
LII icon
14
Lennox International
LII
$14.4B
$3.64M 2.37%
25,500
– –
TMO icon
15
Thermo Fisher Scientific
TMO
$213B
$3.56M 2.32%
24,120
– –
ROP icon
16
Roper Technologies
ROP
$38.8B
$3.51M 2.29%
20,563
+1,450
+8% +$254K
DHR icon
17
Danaher
DHR
$137B
$3.5M 2.28%
51,598
– –
ECL icon
18
Ecolab
ECL
$78.1B
$3.48M 2.27%
29,325
– –
PAYX icon
19
Paychex
PAYX
$41.6B
$3.47M 2.26%
58,312
– –
XYL icon
20
Xylem
XYL
$27.3B
$3.39M 2.21%
75,870
-1,300
-2% -$56.5K
ADSK icon
21
Autodesk
ADSK
$49.5B
$3.36M 2.19%
62,074
+100
+0.2% +$5.79K
LH icon
22
Labcorp
LH
$25B
$3.25M 2.12%
29,056
-7,682
-21% -$827K
WWD icon
23
Woodward
WWD
$21.3B
$3.2M 2.08%
55,450
– –
HEI icon
24
HEICO Corp
HEI
$49.8B
$2.96M 1.93%
108,276
– –
TFX icon
25
Teleflex
TFX
$6.05B
$2.94M 1.92%
16,595
– –
1
2 3

Similar funds

TCB
Texas Capital Bancshares Dallas, Texas $254M AUM 27.01% 1-Year Est. Return
OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
SSW
Smith Shellnut Wilson Ridgeland, Mississippi $260M AUM 19.19% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WS
Wela Strategies Atlanta, Georgia $264M AUM 16.32% 1-Year Est. Return
MTWM
Masso Torrence Wealth Management Marlton, New Jersey $240M AUM 26.41% 1-Year Est. Return
KSWA
Kathleen S. Wright Associates Pittsburgh, Pennsylvania $270M AUM 12.59% 1-Year Est. Return
GA
Guerra Advisors Miami, Florida $271M AUM 27.78% 1-Year Est. Return

Stone Run Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Stone Run Capital held 71 positions worth $153M, down 1.1% from $155M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Stone Run Capital withdrew a net $8.83M in Q2 2016, closing 4 positions and reducing 14 holdings. Its most notable exit was Airgas Inc, an estimated $5.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Industrials and Materials.

Against the trend, Stone Run Capital opened a new position in Illumina worth $835K.

  • Stone Run Capital's largest Q2 2016 buy was Illumina: 6,117 shares worth $835K.
  • Stone Run Capital added most to SLB Ltd in Q2 2016, an estimated $1.91M increase.
  • Stone Run Capital's biggest Q2 2016 reduction was Labcorp, cutting an estimated $827K.
  • Stone Run Capital fully exited Airgas Inc in Q2 2016, selling an estimated $5.57M.
  • Stone Run Capital's ten largest holdings make up 34% of its $153M portfolio in Q2 2016.
  • Stone Run Capital opened 4 new positions and closed 4 in Q2 2016.
  • Stone Run Capital's portfolio value fell 1.1% quarter-over-quarter to $153M.

Based on Stone Run Capital's 13F filing for Q2 2016, filed 15 Aug 2016.